Clinical utility in maximizing CD34+ cell count in stem cell grafts.
Many different stem cell subsets have been identified. Some of these subsets are multipotent, able to develop into any one of several cell types, while other stem cell subsets are committed to differentiated myeloid, lymphoid, erythroid, or megakaryocytic lineages.
Burt
R K
RK
Allogeneic Transplantation, Northwestern University, Chicago, Illinois 60612, USA.
D018952:Antigens, CD34 / Q000032:analysis*; D015415:Biomarkers; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000737:chemistry* / Q000166:cytology*; D006801:Humans; D007958:Leukocyte Count / Q000379:methods
D018952:Antigens, CD34; D015415:Biomarkers